A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
Status: Recruiting
Location: See all (32) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years inclusive at the time of signing the ICF
• Allogeneic SCT 90 to 180 days prior to enrollment
• Able to comprehend and willing to provide informed consent
• Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel
Locations
United States
Alabama
University of Alabama Birmingham
RECRUITING
Birmingham
Arizona
Mayo Clinic Arizona
RECRUITING
Phoenix
California
City of Hope
RECRUITING
Duarte
USC Norris Comprehensive Cancer Center
RECRUITING
Los Angeles
Colorado
University of Colorado
RECRUITING
Aurora
Florida
Mayo Clinic Jacksonville
RECRUITING
Jacksonville
AdventHealth Orlando
RECRUITING
Orlando
Moffit Cancer Center
RECRUITING
Orlando
Georgia
Emory University
RECRUITING
Atlanta
Georgia Cancer Center
RECRUITING
Augusta
Illinois
Northwestern University
RECRUITING
Chicago
Rush University Medical Group
RECRUITING
Chicago
The University of Chicago
RECRUITING
Chicago
Loyola University Medical Center
RECRUITING
Maywood
Kansas
The University of Kansas Clinical Research Center
RECRUITING
Fairway
Louisiana
Tulane Cancer Center
COMPLETED
New Orleans
Massachusetts
Massachusetts Cancer Research Center
RECRUITING
Boston
Maryland
University of Maryland Medical Center
RECRUITING
Baltimore
Michigan
Corewell Health
RECRUITING
Grand Rapids
Minnesota
Mayo Clinic Rochester
RECRUITING
Rochester
North Carolina
University of North Carolina at Chapel Hill
RECRUITING
Chapel Hill
Levine Cancer Institute
RECRUITING
Charlotte
New Jersey
Rutgers Cancer Institute of New Jersey
RECRUITING
New Brunswick
New York
Memorial Sloan Kettering Cancer Center
RECRUITING
New York
Ohio
The Ohio State University
RECRUITING
Columbus
Oregon
Oregon Health Sciences University
RECRUITING
Portland
Pennsylvania
Geisinger Health Systems
RECRUITING
Danville
Tennessee
Vanderbilt University Medical Center
RECRUITING
Nashville
Texas
Texas Oncology-Baylor Charles A. Sammons Cancer Center
RECRUITING
Dallas
Utah
University of Utah, Huntsman Cancer Institute
RECRUITING
Salt Lake City
Washington
Fred Hutchinson Cancer Research Center
RECRUITING
Seattle
Wisconsin
Medical College of Wisconsin
RECRUITING
Milwaukee
Contact Information
Primary
Incyte Corporation Call Center (US)
medinfo@incyte.com
1.855.463.3463
Backup
Incyte Corporation Call Center (ex-US)
eumedinfo@incyte.com
+800 00027423
Time Frame
Start Date: 2023-08-01
Estimated Completion Date: 2027-10-15
Participants
Target number of participants: 1500
Treatments
At risk for GVHD
Equal or Greater than 18 years old post alloSCT
Related Therapeutic Areas
Sponsors
Leads: Incyte Corporation